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Background: Metabolic syndrome has been reported to have adverse effects on cognitive function, although the results 
are conﬂ  icting. The purpose of this study was to examine the relationship between metabolic syndrome and cognitive 
function in elderly Korean participants older than 60 years. 
Methods: We examined elderly participants who visited the health promotion center in Gyeonggi-do province. We 
categorized the participants into two groups based on the presence of metabolic syndrome (48 participants in the 
metabolic syndrome group and 45 in the control group). Cognitive function was assessed in all participants using the 
Korean version of the Consortium to Establish a Registry for Alzheimer’s Disease (CERAD-K).
Results: Compared with those without metabolic syndrome, participants with metabolic syndrome had lower mean total 
CERAD-K scores (64.2 ± 11.1 vs. 69.8 ± 9.2, P = 0.010). In the comparison of CERAD-K items, signiﬁ  cantly lower scores 
were observed in the verbal ﬂ  uency test, the construction recall test, the word list learning test, and trail making B in the 
group with metabolic syndrome. After controlling age, sex, education, smoking, alcohol, physical activity and the Korean 
version of the Short Geriatric Depression Scale of Korean, multiple regression analysis showed that metabolic syndrome 
was independently associated with cognitive function (P = 0.014). Alcohol intake (P = 0.002) and education years (P = 0.001) 
were also contributing factors to cognitive function.
Conclusion: This study found a signiﬁ  cant relationship between cognitive function and metabolic syndrome. It will be 
necessary to perform a prospective study to determine whether metabolic syndrome causes cognitive dysfunction or if 
the correction of metabolic syndrome can improve cognitive function.
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INTRODUCTION
The proportion of people aged 65 years and over in South 
Korea is expected to increase from 7.3 % in 2000 to 15.1% 
in 2020. Accordingly, the health problems of the elderly gain 
increasing importance in socio-economic terms.
1) Dementia is a 
socially important disease among the senile disorders because it 
has a high prevalence and deteriorates comprehensive cognitive 
functions, behaviors and mental functions, considerably 
inconveniencing vocational and social activities and signifi  cantly 
reducing the quality of life. As the geriatric population increases 
rapidly, the number of elderly people with dementia is also 
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expected to increase dramatically. In Korea, the incidence of 
dementia in 2008 was 8.68%, and the number of patients with 
dementia was estimated at 430,000. It is expected that the 
prevalence of dementia will increase continuously to an estimated 
1,140,000 patients in 2030, with a two-fold increase per 20 years.
2) 
Hence, it is important to attempt to decrease the occurrence of 
dementia by determining and eliminating its risk factors as well as 
detecting and treating dementia early.
Many studies have reported relationships between dementia 
and vascular risk factors such as glucose intolerance, insulin 
resistance, central obesity, lipid abnormalities and hypertension.
3) 
Hypertension,
4,5) diabetes
6,7) and hyperlipidemia
8,9) play important 
roles in the pathogenesis of impaired cognitive function and are 
related to the increase of Alzheimer’s disease as well as other types 
of dementia.
10) Metabolic syndrome is a cluster of cardiovascular 
risk factors, and its prevalence is increasing signifi  cantly in Korea. 
Although diagnostic criteria diff  er, metabolic syndrome is found 
in 32.6% of adults 30 years old or older according to the 2005 
National Health and Nutrition Survey,
11) and a study on diabetes 
found the prevalence of metabolic syndrome to be 62.0%.
12)
With the drastic increase in the prevalence of metabolic 
syndrome around the world and in South Korea, studies are 
examining the relationship between metabolic syndrome and 
cognitive function. Yaff  e et al.
13) reported a decrease in cognitive 
function with metabolic syndrome. However, previous studies 
are limited in that they have not measured cognitive function 
comprehensively. Most of previous studies have applied simple 
tests, such as the Mini-Mental State Examination (MMSE), to the 
evaluation of cognitive function and have not accurately assessed 
early dementia or mild cognitive disorder.
14,15) The MMSE is 
a simple method that is high in sensitivity and specificity, but 
it is limited in measuring cognitive function comprehensively. 
Th   erefore, it is recommended that cognitive tests for the elderly 
jointly use the comprehensive measurement tool.
16,17) In South 
Korea, Moon et al.
18) reported the relationship between metabolic 
syndrome and cognitive function in adults older than 50, but no 
study has examined this relationship among the elderly, who are 
in the high-risk of dementia and metabolic syndrome. 
This study investigated the relationship between metabolic 
syndrome and cognitive function among elderly persons using 
the CERA   D-K, a more precise evaluation method than MMSE.
METHODS
1. Subjects
The subjects were elderly people who had no difficulties in 
daily life and consented to participate in the study aft  er receiving 
a suffi   cient explanation of its purposes and content. Participants 
included adults 60 years old and older who were screened at 
the health promotion center of a university hospital or who 
attended a health program at the Dongtan public health center 
from March 2010 through July 2010 in Gyeonggi-do province. 
Ninety fi  ve volunteers were recruited, and 2 were excluded due 
to cerebrovascular history. Thus, cognitive function tests were 
performed on 93 subjects. When a subject visited the hospital, 
an inquiry and history taking were conducted, which included 
information on age, gender, education, vocation, smoking, 
drinking, exercise and underlying disorders and cognitive 
functions; and a cognitive function test was performed. Smokers 
were classified into current smokers, past smokers who had 
not smoked in the past year, and non-smokers who had never 
smoked. Drinking frequency was divided into no drinking, 
drinking 6 or more times per week, 3-5 times per week, 1 or 
2 times per week and less than once per week. Frequency of 
exercise for 30 minutes or more was categorized into 3 or more 
times a week, once or twice a week and hardly ever. Trained 
nurses measured participants’ height, weight, waist circumference 
and blood pressure and conducted blood tests. Excluded from the 
study are those who had or were suspected of having dementia 
(based on the DSM-IV), had any problems in daily life, were 
unable to communicate or had cerebrovascular disease or cancer 
that might lower cognitive function.
2. Evaluation of Cognitive Function
Experienced doctors evaluated the subjects using the Korean 
version of the Consortium to Establish a Registry for Alzheimer's 
Disease (CERAD-K).
19) The CERAD-K neuropsychological 
assessment batt  ery (CERA   D-K[N]) is a standardized evaluation 
tool for the early diagnosis of dementia. The test takes a short 
time, approximately 30-40 minutes, and is relatively easy to 
perform. Thus, it is very useful for the evaluation of elderly 
patients with dementia. The CERAD-K neuropsychological 
evaluation consists of nine neuropsychological subtests (verbal 
fluency test, modified Boston naming test, Korean version of Hye-Mi Oh, et al: The Relationship between Metabolic Syndrome and Cognitive Function
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the mini-mental state examination [MMSE], word list memory, 
vonstruction praxis, word list delayed recall, word list recognition, 
construction recall, and trail making tests A and B). The total 
CERA   D-K score was calculated by adding the scores on six tests: 
the verbal fluency test, modified Boston naming test, word list 
memory, construction praxis, word list delayed recall, and word 
list recognition. Th   e maximum of total CERA   D-K score was 100 
points.
20, 21)
Depression was evaluated using the Short Geriatric 
Depression Scale, Korean version (SGDS-K). The SGDS-K 
consists of 15 questions and has been shown to be a reliable 
and valid screening test for geriatric depression.
22) The optimal 
SGDS-K cutoff   point for depression was defi  ned as 8 points. 
3. Metabolic Syndrome 
Meeting the following 3 items or more was defined as 
metabolic syndrome on the basis of National Cholesterol 
Education Program’s Adult Treatment Panel III (NCEP-ATP 
III).
23) Abdominal obesity was defi  ned as the waist circumference 
of ≥ 90 cm (male) and ≥ 85 cm (female), which were 
recommended by the Korean Society for the Study of Obesity 
(KSSO)
24) in 2005: 1) waist circumference (WC) ≥ 90 cm for 
men or ≥ 85 cm for women; 2) TG levels ≥ 150 mg/dL; 3) HDL 
levels < 40 mg/dL for men or < 50 mg/dL for women; 4) systolic 
blood pressure (SBP) ≥ 130 mm Hg or diastolic (DBP) ≥ 85 mm 
Hg, or the use of antihypertensive medication; and 5) fasting 
plasma glucose (FBS) ≥ 100 mg/dL, or the use of anti-diabetic 
medication or insulin.
4. Statistical Analyses
The data were analyzed using the SPSS ver. 13 (SPSS Inc., 
Chicago, IL, USA). The results are expressed as the mean ± 
SD. Chi-square test and independent samples test were used to 
investigate socio-demographic characteristics and biochemical 
tests according to metabolic syndrome. Each item of the 
CERAD-K test was assessed according to metabolic syndrome 
with a multivariate covariance analysis (MANCOVA) after 
adjustment for age, education, and alcohol consumption. 
A multiple regression analysis was conducted to determine 
cognitive function’s association with age, gender, education, 
smoking, alcohol drinking, exercise, depression and metabolic 
syndrome. P-values of less than 0.05 were regarded as statistically 
signifi  cant.
RESULTS
1. Comparison of the General Characteristics 
and Biochemical Tests according to Meta-
bolic Syndrome
Of the 93 subjects, 48 subjects (24 male, 21 female) had 
metabolic syndrome. The incidence was higher in female 
subjects than male (63.8% vs. 31.4%). Of the 48 subjects with 
metabolic syndrome, 20 (41.6%), 14 (29.1%), and 4 (8.3%) 
were taking anti-hypertensive drugs, lipid-lowering agents and 
oral hypoglycemic agents, respectively. Th   ere was no signifi  cant 
difference in age, education, smoking, drinking, exercise or 
depression between the group with metabolic syndrome and 
the control group, but women made up a significantly higher 
part of the group with metabolic syndrome. Compared to the 
control group, the group with metabolic syndrome showed a 
signifi  cantly higher average in body mass index, blood pressure, 
waist circumference and lipid concentration (Table 1).
2. Performance on the Cognitive Function Test 
according to the Presence of Metabolic Syn-
drome
 Th   e total CERA   D-K score was 64.2 ± 11.1 in the group with 
metabolic syndrome, which was signifi  cantly lower compared to 
the value of 69.8 ± 9.2 in the control group. In the comparison of 
CERA   D-K items, signifi  cantly lower scores were observed in the 
Verbal Fluency test, the Construction Recall test, the Word List 
Learning test, and Trail Making B in the group with metabolic 
syndrome. Th   e MMSE-KC score was 26.0 ± 2.6 in the group with 
metabolic syndrome, which was signifi  cantly lower compared to 
27.2 ± 2.0 in the control group (Table 2).
3. Relationships between Metabolic Syndrome 
and Cognitive Function 
 A regression analysis was conducted on age, gender, 
education, physical activity, smoking, drinking, depression 
and metabolic syndrome (Table 3). The presence of metabolic 
syndrome, alcohol consumption, and education were signifi  cantly 
associated with the total CERA   D-K score (P < 0.05). However, Hye-Mi Oh, et al: The Relationship between Metabolic Syndrome and Cognitive Function
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the SGDS-K score had no association with the total CERA  D-K 
score. In terms of education level, cognitive function scores 
were significantly higher among people with more than 7 
years of education compared to those with 3 years or less. In a 
multiple regression analysis using metabolic risk factors (waist 
circumference, TG, HDL, blood pressure, FBS), glucose and 
systolic blood pressure levels aff  ected the total CERA  D-K  score 
(R
2 = 29.4%, P < 0.05) (Table 4). 
DISCUSSION
In this study, the prevalence of metabolic syndrome was 
63.8% in women, which was signifi  cantly high compared to the 
prevalence in men (31.4%). This figure is close to the findings 
of a previous study of the total population (63.4% female, 
34.1% male).
11) Th   e cognitive function was signifi  cantly high in 
participants with 7 or more years of higher education compared 
to those with 3 or fewer years of education. Th  is  fi  nding supports 
Table 1. General characteristics in the elderly with and without metabolic syndrome.
Characteristics
Without metabolic syndrome
(n = 45)
Withmetabolic syndrome
(n = 48)
P-value*
Age (y)  68.2 ± 4.4 69.3 ± 4.4 0.245
Sex 0.005
Male 24 (53.3) 11 (22.9)
Female 21 (46.7) 37 (77.1)
Body mass index (kg/m
2) 22.9 ± 2.7 26.3 ± 2.9 <0.001
Systolic blood press (mm Hg) 126.7 ± 12.6 132.8 ± 12.0 0.019
Diastolic blood press (mm Hg) 74.1 ± 7.9 79.8 ± 7.6  0.001
Waist (cm) 83.2 ± 8.1 94.8 ± 5.8 <0.001
Glucose (mg/dL) 95.2 ± 8.7 111.3 ± 24.5 <0.001
Triglyceride (mg/dL) 100.5 ± 43.9 147.8 ± 80.1  0.001
HDL-cholesterol (mg/dL) 54.9 ± 14.4 47.8 ± 10.2.  0.008
SGDS-K   4.1 ± 3.1  4.2 ± 3.5 0.890
Education (y) 6.2 ± 1.6 5.6 ± 2.2 0.099
Smoking 0.288 
No smoking 31 (68.9) 40 (83.3)
Ex-smoker 8 (17.8) 4 (8.3)
Current smoker 6 (13.3) 4 (8.3)
Drinking  0.988
No drinking 31 (68.9) 33 (68.7)
Current 14 (31.1) 15 (31.3)
Physical activity (times) 0.546
None 9 (20.0) 12 (25.0)
1-2  15 (33.3) 11 (22.9)
≥3  21 (46.7) 25 (52.1)
Values are presented as mean ± SD or number (%).
HDL: high density lipoprotein, SGDS: Short Geriatric Depression Scale. 
*P: by T-test for continuous variables and chi-square test for discrete variables.Hye-Mi Oh, et al: The Relationship between Metabolic Syndrome and Cognitive Function
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the hypothesis that a higher education level delays the occurrence 
of dementia by supplementing cognition.
25) The cognitive 
function was signifi  cantly high in the drinking group compared 
to the non-drinking group. This finding is in contrast to the 
fi  ndings from previous studies that drinking increased the risk of 
dementia.
26) In terms of drinking frequency, 93.1% of participants 
Table 2. CERAD-K scores in study subjects.
Neuropsychological test 
Without metabolic syndrome
(n = 45)
With metabolic syndrome
(n = 48)
P-value*
Language Verbal ﬂ  uency 14.5 ± 3.6 12.8 ± 3.6 0.038
 Modiﬁ  ed Boston naming  11.9 ± 2.3 10.6 ± 2.6 0.179
General MMSE-KC  27.2 ± 2.0 26.0 ± 2.6 0.003
Verbal memory Word list learning 17.9 ± 3.8 17.0 ± 4.6 0.001
  Word list recall 6.0 ± 1.7 5.7 ± 1.9 0.153
  Word list recognition 9.3 ± 0.9 8.8 ± 1.3 0.573
Visual memory Constructional praxis  10.1 ± 1.3 9.4 ± 1.5 0.459
  Constructional recall 7.6 ± 2.7 6.0 ± 6.0 0.008
Attention Trail making A 77.8 ± 56.3 92.5 ± 45.2 0.119
Working memory Trail making B 194.5 ± 87.6 250.7 ± 72.3 0.001
Total score   69.8 ± 9.2  64.2 ± 11.1 0.001
Values are presented as mean ± SD.  
MMSE-KC: mini-mental status examination in the Korean version of the Consortium to Establish a Registry for Alzheimer’s Disease 
(CERAD) assessment packet.
*P: by MANCOVA after adjustment for age, education, alcohol drinking. 
Table 3. Multiple regression analysis demonstrating association 
between several factors and cognitive function.
              Variable β-estimated SE P-value* 
Age (y) -0.218 0.23 0.345
Female   2.19  3.03 0.471
Education (y)
4-6 2.08 3.05 0.50
>7 10.11 2.96 0.001*
Smoking 
Current smoker -4.69 3.88 0.230
Ex-smoker -3.57 3.64 0.329
Alcohol 
Current drinker 6.94 2.22 0.002*
Physical activity (times)
1-2 2.48 2.72 0.365
≥3 4.97 2.57 0.057
SGDS -0.03 0.30 0.908
Metabolic syndrome  -5.07 2.01 0.014*
Coefﬁ  cient of determination (R
2): 0.394, β-estimated: parameter esti-
mate. 
SE: standard error, SGDS: Short Geriatric Depression Scale. 
*P: by multiple regression analysis models. 
Table 4. Multiple regression analysis on the association of 
CERAD-K total score with metabolic risk factors (age, alcohol 
drinking and education level adjusted).
                      Variable β-estimated SE P-value* 
Waist (cm) -0.063 0.116 0.526
Glucose (mg/dL) -0.252 0.047 0.007
Triglyceride (mg/dL) -0.174 0.014 0.064
HDL-C (mg/dL) -0.032 0.079 0.737
Systolic blood press (mm Hg) -0.236 0.078 0.024
Diastolic blood press (mm Hg) -0.166 0.118 0.075
Coefﬁ  cient of determination (R
2): 0.294, β-estimated: parameter esti-
mate.
CERAD-K: Korean version of the Consortium to Establish a Registry 
for Alzheimer’s Disease, SE: standard error, HDL: high density 
lipoprotein.
*P: by multiple regression analysis models.Hye-Mi Oh, et al: The Relationship between Metabolic Syndrome and Cognitive Function
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drank less twice. According to previous studies, a small amount 
of alcohol (i.e., 1-3 standard drinks or less a day) prevents the 
reduction of cognitive function, reduces the risk of dementia
27) 
and deters the progress of dementia in patients with mild 
cognitive disorder.
28) However, the present study is limited by not 
determining accurate amount and types of alcohol drinking. It 
seems necessary to analyze this relationship to cognitive function 
based on an accurate drinking history. Depression symptoms 
were serious in the Alzheimer-type dementia group compared 
to the control group.
29) Many studies report that depression is 
closely related to the lowering of cognitive function, but this study 
found no relationship between SGDS-K scores and cognitive 
function. Because the subjects had normal cognitive function 
with an MMSE score over 26 points and an SGDS-K score under 
8 points, it seems that no depression symptoms were observed 
with regard to the changes in cognitive function. However, it will 
be necessary to conduct additional studies on elderly people in 
the future. 
Recently, many studies have reported a relationship between 
metabolic syndrome and cognitive function. According to a 
prospective study of adults aged 70 years or older, cognitive 
function declined significantly in the group with metabolic 
syndrome.
13) In a 3.5-year prospective study of 2,097 patients 
65 years or older with mild cognitive disorder, Solfrizzi et al.
30) 
reported a significant increase in the risk of progressing from 
mild cognitive disorder to dementia when accompanied by 
metabolic syndrome. Additionally, it is suggested that dementia 
increases with the increase in vascular risk factors, such as 
hypertension, diabetes, hyperlipidemia and smoking, in middle 
age.
31) Based on the mixture of cardiovascular risk factors, 
metabolic syndrome seems to be related to cognitive function. 
In South Korea, Moon et al.
18) reported that cognitive function 
decreased in adults with metabolic syndrome. However, the 
authors assessed cognitive function with the MMSE-K and did 
not perform a comprehensive and detailed analysis of cognitive 
function. In addition, depression symptoms were not considered. 
We assessed the relationship between metabolic syndrome and 
cognitive function in elderly Korean people using the CERAD 
tool. In this study, CERA   D-K total scores were 64.2 ± 11.1 in the 
metabolic syndrome group and 69.8 ± 9.2 in the control group, 
which is consistent with previous fi  ndings on the total CERA  D-K 
score in the Korean population.
21) Cognitive function decreased 
in the metabolic syndrome group compared to the normal 
control group, especially on the verbal fl  uency test, construction 
recall test, word list learning test, trail making B, and the total 
CERAD-K score. This result might indicate the reduction of 
frontal lobe functions related to initial changes in dementia.
In this study, the presence of metabolic syndrome was 
significantly associated with cognitive function. Among the 
metabolic risk factors, fasting plasma glucose and triglyceride 
levels affected the CERAD-K total score. Many studies have 
examined the mechanism by which metabolic syndrome aff  ects 
cognitive function. Insulin resistance and hyperinsulimenia 
in metabolic syndrome cause a decrease in glucose use and 
energy metabolism in the cerebral cortex than in other tissues.
32) 
Furthermore, in cases of hyperinsulimenia, insulysin, which 
decomposes the beta amyloid and plays an important role in 
Alzheimer’s dementia, is better combined with insulin, thus 
depositing beta amyloids and increasing the phosphorylation 
of tau proteins.
33) Cholesterol, a main component of myelin 
and cell membrane, plays an important role in maintaining the 
functions of cerebral tissues. According to Eckert et al.,
34) there 
is a decrease in the membrane fl  uidity of the hippocampus as a 
memory center in Alzheimer’s dementia, which may be related 
to cholesterol disorder. Beta amyloids destroy the cell membrane 
structure of cerebral tissue. A low cholesterol concentration 
causes a reduction in beta amyloid formation in hippocampus 
neurons, thus delaying the occurrence of Alzheimer’s dementia.
34) 
Hypertriglyceridemia changes cerebral blood by increasing 
the viscosity of blood and lowers cognitive function by causing 
arteriosclerosis.
35) Hypertension is said to decrease the number 
of nicotinic receptors sensitive to acetylcholine and to cause 
cerebrovascular diseases, cerebral infarction and cerebral gray 
substances, arteriosclerosis and lower cognitive function.
36) A 
chronic high blood sugar level deters the synthesis and secretion 
of cerebral acetylcholine
37) and causes the loss of neurons in the 
cerebral cortex and the reduction of glucose levels in cells, leading 
to a decrease in cognitive function.
38) 
Given the studies that suggest the high possibility that a 
decrease in cognitive function or mild cognitive function disorder 
will develop into dementia,
39) elderly individuals with metabolic 
syndrome have a lower cognitive function compared to the 
control group, and they are likely to develop dementia, although 
they do not currently suff  er from dementia. Accordingly, the early Hye-Mi Oh, et al: The Relationship between Metabolic Syndrome and Cognitive Function
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detection and correction of metabolic syndrome in adults is likely 
to decrease cardiovascular diseases and to reduce the decrease 
of cognitive function and the risk of dementia. Given that early 
detection and treatment are eff  ective for senile dementia, it seems 
that the precise assessment of cognitive function will be helpful 
for metabolic syndrome patients. 
Our study has the following limitations. First, the subjects of 
this study are individuals who participated in a health promotion 
program of a hospital. Thus it is necessary to be cautious in 
applying the study results to normal population groups. Second, 
there were more women in the group with metabolic syndrome 
than in the control group. However, this trend is similar to the 
gender distribution in the elderly Korean population. There 
were statistically significant relationships between metabolic 
syndrome and cognitive function even aft  er adjusting for gender 
and education. Th   ird, this was cross-sectional study to assess the 
relationship between metabolic syndrome and cognitive function, 
but it was diffi   cult to evaluate causal relationships. However, this 
study is signifi  cant in that it analyzed the relationships between 
metabolic syndrome and cognitive function in elderly Korean 
individuals using the CERA   D tool. It will be necessary to perform 
a prospective study to determine whether metabolic syndrome 
causes cognitive dysfunction or dementia and whether the 
correction of cardiovascular risk factors can improve cognitive 
function.
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